Analysis of information sources in references of the Wikipedia article "GISAID" in English language version.
With more than 700,000 genomes from more than 160 countries, GISAID is by far the world's largest database of SARS-CoV-2 sequences
the global sampling of SARS-CoV-2 is being very capably addressed by the Global Initiative for Sharing All Influenza Data (GISAID) database
During the first year of the pandemic, a large number of SARS-CoV-2 whole-genome sequences were generated from all around the world and shared, mostly through GISAID.
According to GISAID, the percentage of all active users whose access credentials to the GISAID platform have been revoked at the time of writing is around 0.16%.
The Scientific Advisory Council (SAC) advises and supports the Initiative in pursuit of its public health and scientific objectives. Its members are leading scientists with expertise in virology, microbiology, computational and molecular biology, epidemiology, evolutionary genomics and bioinformatics, and public health or animal-health..
According to GISAID, the percentage of all active users whose access credentials to the GISAID platform have been revoked at the time of writing is around 0.16%.
More than 1.2 million coronavirus genome sequences from 172 countries and territories have now been shared on a popular online data platform
The omicron variant... accounted for 78% of genetically sequenced positive New York COVID samples uploaded to GISAID, the world's largest repository of COVID-19 sequences, over the last two weeks.
China, Russia and other nations that have long withheld influenza-virus samples and DNA-sequencing data from the international community are also taking part in the initiative, saying it offers full transparency and, for the first time, basic protection of intellectual-property rights.
the global sampling of SARS-CoV-2 is being very capably addressed by the Global Initiative for Sharing All Influenza Data (GISAID) database
During the first year of the pandemic, a large number of SARS-CoV-2 whole-genome sequences were generated from all around the world and shared, mostly through GISAID.
According to GISAID, the percentage of all active users whose access credentials to the GISAID platform have been revoked at the time of writing is around 0.16%.
the global sampling of SARS-CoV-2 is being very capably addressed by the Global Initiative for Sharing All Influenza Data (GISAID) database
According to GISAID, the percentage of all active users whose access credentials to the GISAID platform have been revoked at the time of writing is around 0.16%.
With more than 700,000 genomes from more than 160 countries, GISAID is by far the world's largest database of SARS-CoV-2 sequences
GISAID further required that data users not only give credit to data submitters, but make maximum efforts to work with and include them in joint analyses on viral sequence data, further tipping the scales in favor of collaboration. This mandated sharing of not only data, but the benefits of research, has resulted in a paradigm shift which helps to put contributors from higher or lower resource settings on the same footing. ... Adopting a system of credit sharing similar to GISAID's would ensure that regardless of resource setting, data depositors are incentivized and recognized.
With more than 700,000 genomes from more than 160 countries, GISAID is by far the world's largest database of SARS-CoV-2 sequences
During the first year of the pandemic, a large number of SARS-CoV-2 whole-genome sequences were generated from all around the world and shared, mostly through GISAID.
According to GISAID, the percentage of all active users whose access credentials to the GISAID platform have been revoked at the time of writing is around 0.16%.
as of July 20, a total of over 2.4 million SARS-CoV-2 sequences have been submitted to GISAID
